Corporate Info Research Reports Consulting News Contact Us
 

 

Consulting Services

Let Cutting Edge Information help you build revenues, reduce costs, and increase efficiency.

Call Jason Richardson at 919-403-6583 today to learn more about our customized research and get a free quote.

 

A Product Director's Guide to Promotional Mix (PH87)

Purchase E-Copy Now
Download Free Report Summary

Published 2006
181 Pages
9 Profiled Brands
350+ Metrics
135+ Charts and Diagrams

  Overview

Companies Metrics Content

Call Oveda Slade at 919-403-6583 to get your own copy of "A Product Director's Guide to Promotional Mix" today.
 
Sample Content
(The following is an introduction to a brand profile.  The full profile contains in-depth discussion of spending patters accompanied by three tables of brand resource data and eight data charts.)

Brand 6 faced some unique challenges as it entered a market with virtually no direct competitors. Although this lack of competition was an advantage in some regards, it also meant that the company had to invest significant resources and time to increase market awareness of the product and the condition it treats. To reach the drug’s peak projected annual sales of $250 to $500 million, Brand 6’s developer will have to continue to devote targeted resources to overcome gaps in physician knowledge.

As a specialized pharmaceutical, the drug offers physicians a unique way to treat Brand 6’s intended patients. Although the drug is not a first-line therapy, it is often used in conjunction with other treatments to have the greatest effect.

The brand had to create a market for itself, as specialists were unfamiliar with treating this disease state. The developer relied on its sales force and detail aids to help effectively commercialize the brand. In fact, in the first three years the developer drew on a $x million to develop, manufacture and distribute detailing materials.

In addition to an immature market, Brand 6 also suffered from its developer’s marketing inexperience. With no other competitors to benchmark, Brand 6’s team developed its own forecasts and strategies. Brand 6’s developer was small and relatively inexperienced, and the drug was the company’s flagship product. It received considerable attention and financial support, since the developer knew its future depended on Brand 6’s success. After the brand’s first year on the market, however, the company was acquired by a big pharma company that now runs the smaller company as a subsidiary. This development affected the company’s structure and the resources allocated to Brand 6's marketing efforts.

Commercial Priorities and Challenges

One of the greatest challenges Brand 6’s team had to overcome was the lack of a market for the drug. The product addressed a distinct unmet need, but specialists were not aware of the drug, nor were they used to treating this disease with a prescription pharmaceutical. To address this challenge, the brand team focused its promotion on market awareness and education for both patients and the medical community.

The company, for example, met with several medical schools to help inform students and physicians about this new treatment option. By going to the source of medical education, the company hopes to expand the future market for its product.

The brand team also addressed specialists' unfamiliarity with pharmaceuticals designed for the condition in question. Though Brand 6’s developer had to blaze its own trail in this area, the lack of direct competition allowed the company to establish itself as a leading provider in this marketplace. Fortunately, targeted specialists are not as overwhelmed as other physicians because few sales reps call on them. This fact gives Brand 6’s reps more time with their sales targets...

 

CORPORATE INFO RESEARCH REPORTS CONSULTING NEWS CONTACT US HOME
Copyright (c) Cutting Edge Information  p:919-403-6583  Please read our Copyright Policy